201
Views
19
CrossRef citations to date
0
Altmetric
Review

Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations

ORCID Icon, , , , ORCID Icon, & ORCID Icon show all
Pages 963-978 | Received 26 Jan 2021, Accepted 06 May 2021, Published online: 26 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Mattia Galli & Dominick J Angiolillo. (2023) How is pharmacogenetics changing clinical trial design for percutaneous coronary intervention?. Expert Review of Clinical Pharmacology 16:5, pages 383-385.
Read now
Georg Gelbenegger & Bernd Jilma. (2022) Clinical pharmacology of antiplatelet drugs. Expert Review of Clinical Pharmacology 15:10, pages 1177-1197.
Read now
Placido Maria Mazzone, Dominick J. Angiolillo & Davide Capodanno. (2022) Approaches to de-escalation of antiplatelet treatment in stabilized post-myocardial infarction patients with high ischemic risk. Expert Review of Cardiovascular Therapy 20:10, pages 839-849.
Read now

Articles from other publishers (16)

Rossella Marcucci, Martina Berteotti, Felice Gragnano, Mattia Galli, Ilaria Cavallari, Giulia Renda, Piera Capranzano, Francesca Santilli, Davide Capodanno, Dominick J. Angiolillo, Plinio Cirillo, Paolo Calabrò, Giuseppe Patti & Raffaele De Caterina. (2023) Monitoring antiplatelet therapy: where are we now?. Journal of Cardiovascular Medicine 24:Supplement 1, pages e24-e35.
Crossref
Mattia Galli, Francesco Franchi, Fabiana Rollini & Dominick J. Angiolillo. (2023) Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention. Trends in Cardiovascular Medicine 33:3, pages 133-138.
Crossref
Larisa H. Cavallari & Francesco Franchi. (2023) Genotype-Guided Selection of Antiplatelet Therapy. JACC: Cardiovascular Interventions 16:7, pages 844-846.
Crossref
M. Berteotti, A. M. Gori, B. Giusti, A. Fortini, G. Grossi, N. Ciardetti, A. Migliorini, E. Lotti, R. Valenti, C. Di Mario, N. Marchionni & R. Marcucci. (2023) Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy. Journal of Thrombosis and Thrombolysis 55:4, pages 667-679.
Crossref
Mattia Galli, Francesco Costa & Dominick J. Angiolillo. (2023) Editorial: Precision medicine for antithrombotic therapy in patients after percutaneous coronary interventions. Frontiers in Cardiovascular Medicine 10.
Crossref
Qiao-Yu Shao, Zhi-Jian Wang, Xiao-Teng Ma, Yu-Fei Wang, Qiu-Xuan Li, Zhi Qiang Yang, Xu-Ze Lin, Liu Pan, Fei Gao, Li Xia Yang, Jing Liang & Yu-Jie Zhou. (2022) Mortality of Escalation and Modulation Antithrombotic Therapy in Coronary Artery Disease Patients: A Meta-analysis of Randomized Controlled Trials. Thrombosis and Haemostasis 123:01, pages 108-117.
Crossref
Felice Gragnano, Antonio Capolongo, Fabrizia Terracciano, Giuseppe Gargiulo, Vincenzo De Sio, Arturo Cesaro, Elisabetta Moscarella, Giuseppe Patti, Italo Porto, Giovanni Esposito, Dominick J. Angiolillo & Paolo Calabrò. (2022) Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice. Journal of Clinical Medicine 11:21, pages 6246.
Crossref
Mattia Galli & Dominick J. Angiolillo. (2022) De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?. Frontiers in Cardiovascular Medicine 9.
Crossref
Dorota Danielak, Kornel Pawlak, Franciszek Główka & Marta Karaźniewicz-Łada. (2022) Influence of Genetic and Epigenetic Factors of P2Y12 Receptor on the Safety and Efficacy of Antiplatelet Drugs. Cardiovascular Drugs and Therapy.
Crossref
Mattia Galli, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini & Dominick J Angiolillo. (2022) Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention. Pharmacogenomics 23:13, pages 723-737.
Crossref
Dominick Angiolillo Angiolillo, Mattia Galli, Jean-Philippe Collet, Adnan Kastrati & Michelle O'Donoghue O'Donoghue. (2022) Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention 17:17, pages e1371-e1396.
Crossref
Mattia Galli, Stefano Benenati, Francesco Franchi, Fabiana Rollini, Davide Capodanno, Giuseppe Biondi-Zoccai, Giovanni Maria Vescovo, Larisa H Cavallari, Behnood Bikdeli, Jurrien ten Berg, Roxana Mehran, Charles Michael Gibson, Filippo Crea, Naveen L Pereira, Dirk Sibbing & Dominick J Angiolillo. (2022) Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials. European Heart Journal 43:10, pages 959-967.
Crossref
Davide Capodanno, Dominick J. Angiolillo, Ryan J. Lennon, Shaun G. Goodman, Sang‐Wook Kim, Fearghas O'Cochlain, Derek Y. So, John Sweeney, Charanjit S. Rihal, Michael Farkouh & Naveen L. Pereira. (2022) ABCD‐GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial. Journal of the American Heart Association 11:4.
Crossref
Abdullah M. Al-Rubaish, Fahad A. Al-Muhanna, Abdullah M. Alshehri, Mohammed A. Al-Mansori, Rudaynah A. Alali, Rania M. Khalil, Khalid A. Al-Faraidy, Cyril Cyrus, Mohammed M. Sulieman, Chittibabu Vatte, Bao-Li Loza, Daniel M.F. Claassens, Folkert W. Asselbergs & Amein K. Al-Ali. (2021) Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients. International Journal of Cardiology 343, pages 15-20.
Crossref
Wenbin Lu, Yu Wang, Lijuan Chen, Yongjun Li, Rui Zhang, Zhongpu Chen, Jinchuan Yan, Mingming Yang, Bing Han, Zhirong Wang, Shenghu He, Lianglong Chen, Xiang Wu, Hesong Zeng, Likun Ma, Guoping Shi, Jianrong Yin, Jiyan Chen & GenShan Ma. (2021) Antithrombotic Therapy With Ticagrelor in Atrial Fibrillation Subjects After Percutaneous Coronary Intervention. Frontiers in Cardiovascular Medicine 8.
Crossref
Mattia Galli & Dominick J. Angiolillo. (2021) Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized controlled trials. Current Opinion in Cardiology 36:4, pages 390-396.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.